A detailed history of Crewe Advisors LLC transactions in Laboratory Corp Of America Holdings stock. As of the latest transaction made, Crewe Advisors LLC holds 44 shares of LH stock, worth $9,300. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44
Holding current value
$9,300
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$209.01 - $232.56 $9,196 - $10,232
44 New
44 $9,000
Q4 2022

Feb 07, 2023

SELL
$203.72 - $248.97 $1,629 - $1,991
-8 Reduced 72.73%
3 $0
Q3 2022

Nov 14, 2022

BUY
$204.81 - $262.19 $2,252 - $2,884
11 New
11 $2,000
Q3 2021

Oct 29, 2021

SELL
$274.82 - $308.34 $8,244 - $9,250
-30 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$251.87 - $278.14 $6,296 - $6,953
-25 Reduced 45.45%
30 $8,000
Q3 2020

Oct 13, 2020

BUY
$167.03 - $201.3 $9,186 - $11,071
55 New
55 $10,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $18.9B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Crewe Advisors LLC Portfolio

Follow Crewe Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crewe Advisors LLC with notifications on news.